Genetic variations in benzene metabolism and susceptibility to multiple myeloma

Leukemia Research

Volumn 31, Issue 6, 2007, Pages 759-763

  Lincz, Lisa F ^a,b,d   Scorgie, Fiona E ^a,d   Robertson, Richard ^a,b,d   Enno, Arno ^a,c,d  

^a NEWCASTLE MATER HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c Hunter Area Medical Service   (Australia)

^d HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Benzene metabolism; Genetic predisposition to disease; Multiple myeloma; Polymorphisms

Indexed keywords

BENZENE; EPOXIDE HYDROLASE; FLAVOPROTEIN; GLUTATHIONE TRANSFERASE T1; NICOTINAMIDE ADENINE DINUCLEOTIDE; OXIDOREDUCTASE; QUINONE DERIVATIVE;

ADULT; AGED; ARTICLE; BENZENE METABOLISM; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; GSTT1 GENE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEH GENE; MULTIPLE MYELOMA; NQO1 GENE; NULL ALLELE; PRIORITY JOURNAL; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BENZENE; CASE-CONTROL STUDIES; EPOXIDE HYDROLASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NADH, NADPH OXIDOREDUCTASES; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 34249790559     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2006.07.012     Document Type: Article

References (23)

1. Lincz L.F., Kerridge I., Scorgie F.E., Bailey M., Enno A., and Spencer A. Xenobiotic gene polymorphisms and susceptibility to multiple myeloma. Haematologica 89 5 (2004) 628-629
2. Autrup H. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. Mutat Res 464 1 (2000) 65-76
3. Snyder R., and Hedli C.C. An overview of benzene metabolism. Environ Health Perspect 104 Suppl. 6 (1996) 1165-1171
4. Rothman N., Smith M.T., Hayes R.B., Traver R.D., Hoener B., Campleman S., et al. Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C→T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res 57 14 (1997) 2839-2842
5. Wan J., Shi J., Hui L., Wu D., Jin X., Zhao N., et al. Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning. Environ Health Perspect 110 12 (2002) 1213-1218
6. Aksoy M., Erdem S., and DinCol G. Leukemia in shoe-workers exposed chronically to benzene. Blood 44 6 (1974) 837-841
7. Lan Q., Zhang L., Li G., Vermeulen R., Weinberg R.S., Dosemeci M., et al. Hematotoxicity in workers exposed to low levels of benzene. Science 306 5702 (2004) 1774-1776
8. Rana S.V., and Verma Y. Biochemical toxicity of benzene. J Environ Biol 26 2 (2005) 157-168
9. Pyatt D. Benzene and hematopoietic malignancies. Clin Occup Environ Med 4 3 (2004) 529-555 [vii]
10. Korhonen S., Romppanen E.-L., Hiltunen M., Helisalmi S., Punnonen K., Hippelainen M., et al. Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are associated with polycystic ovary syndrome. Fertil Steril 79 6 (2003) 1353-1357
11. London S.J., Lehman T.A., and Taylor J.A. Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res 57 22 (1997) 5001-5003
12. Ozawa S., Schoket B., McDaniel L.P., Tang Y.-M., Ambrosone C.B., Kostic S., et al. Analyses of bronchial bulky DNA adduct levels and CYP2C9, GSTP1 and NQO1 genotypes in a Hungarian study population with pulmonary diseases. Carcinogenesis 20 6 (1999) 991-995
13. Hayashi S., Watanabe J., and Kawajiri K. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem (Tokyo) 110 4 (1991) 559-565
14. Yoshikawa M., Hiyama K., Ishioka S., Maeda H., Maeda A., and Yamakido M. Microsomal epoxide hydrolase genotypes and chronic obstructive pulmonary disease in Japanese. Int J Mol Med 5 1 (2000) 49-53
15. Garte S., Gaspari L., Alexandrie A.K., Ambrosone C., Autrup H., Autrup J.L., et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 10 12 (2001) 1239-1248
16. Xu L.L., Liu G., Miller D.P., Zhou W., Lynch T.J., Wain J.C., et al. Counterpoint: the myeloperoxidase -463G-a polymorphism does not decrease lung cancer susceptibility in Caucasians. Cancer Epidemiol Biomarkers Prev 11 12 (2002) 1555-1559
17. Hassett C., Aicher L., Sidhu J.S., and Omiecinski C.J. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 3 3 (1994) 421-428
18. Ye Z., and Song H. Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: a systematic review and meta-analysis. Eur J Cancer 41 7 (2005) 980-989
19. Nebert D.W., Roe A.L., Vandale S.E., Bingham E., and Oakley G.G. NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review. Genet Med 4 2 (2002) 62-70
20. Morgan G.J., and Smith M.T. Metabolic enzyme polymorphisms and susceptibility to acute leukemia in adults. Am J Pharmacogenomics 2 2 (2002) 79-92
21. Ross D. Functions and distribution of NQO1 in human bone marrow: potential clues to benzene toxicity. Chem Biol Interact 153-154 (2005) 137-146
22. Krajinovic M., Sinnett H., Richer C., Labuda D., and Sinnett D. Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Int J Cancer 97 2 (2002) 230-236
23. Yuille M., Condie A., Hudson C., Kote-Jarai Z., Stone E., Eeles R., et al. Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia. Blood 99 11 (2002) 4216-4218